WP
NGNE icon

Woodline Partners’s Neurogene NGNE Stock Holding History

Woodline Partners’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Hold
83,835
– – 0.01% 824
2025
Q4 		$1.73M Hold
83,835
– – 0.01% 787
2025
Q3 		$1.45M Hold
83,835
– – 0.01% 765
2025
Q2 		$1.25M Buy
83,835
+425
+0.5% +$6.67K 0.01% 783
2025
Q1 		$977K Buy
83,410
+70
+0.1% +$1.22K 0.01% 766
2024
Q4 		$1.91M Buy
83,340
+252
+0.3% +$9.38K 0.01% 659
2024
Q3 		$3.49M Buy
+83,088
New +$3.22M 0.03% 431

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Woodline Partners's NGNE Position: Q1 2026 in Review

Woodline Partners held its Neurogene (NGNE) position steady in Q1 2026 at 83,835 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #824.

Woodline Partners first reported a position in NGNE in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.49M in Q3 2024. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Woodline Partners held 83,835 shares of Neurogene worth $1.69M as of Q1 2026.
  • Woodline Partners left its Neurogene share count unchanged in Q1 2026.
  • Neurogene made up 0.01% of Woodline Partners's portfolio in Q1 2026, its #824 holding.
  • Woodline Partners first reported a position in Neurogene in Q3 2024 and has held it in 7 quarters since.
  • Woodline Partners's Neurogene position peaked at $3.49M in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.